# Endologix clinical trials: 25 on ClinicalTrials.gov (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25 trials with Endologix as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Endologix: 25 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/endologix

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 25, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 25, 2025 | NCT06990048 | The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System | Endologix | Observational | Active not recruiting | Abdominal Aortic Aneurysm | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06990048) |
| March 18, 2024 | NCT06315023 | The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry) | Endologix | Observational | Enrolling by invitation | Peripheral Arterial Disease, Symptomatic Femoropopliteal Lesions | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06315023) |
| June 8, 2022 | NCT05409118 | JAGUAR Trial (Outside United States; OUS): ObJective Analysis to GaUge EVAR Outcomes Through Randomization | Endologix | Not applicable | Withdrawn | AAA, AAA - Abdominal Aortic Aneurysm | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05409118) |
| October 1, 2021 | NCT05064540 | JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization | Endologix | Not applicable | Recruiting | AAA, AAA - Abdominal Aortic Aneurysm | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05064540) |
| November 12, 2020 | NCT04625660 | Detour2 Continued Access Study | Endologix | Not applicable | Completed | Peripheral Artery Diseases | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04625660) |
| February 5, 2020 | NCT04252573 | Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication | Endologix | Not applicable | Active not recruiting | 1 Paravisceral Abdominal Aortic Aneurysm, 2 Juxtarenal Abdominal Aortic Aneurysm, 3 Pararenal Abdominal Aortic... | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04252573) |
| October 17, 2019 | NCT04130737 | The PQ Bypass Pivotal IDE Intra-arterial Stent Graft Study | Endologix | Not applicable | Completed | Peripheral Arterial Disease | 188 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04130737) |
| October 2, 2017 | NCT03298477 | EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study | Endologix | Not applicable | Completed | Abdominal Aortic Aneurysm Without Rupture | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03298477) |
| April 25, 2017 | NCT03128424 | TORUS I Clinical Study | Endologix | Not applicable | Completed | Peripheral Arterial Disease | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03128424) |
| April 18, 2017 | NCT03119233 | The DETOUR 2 Clinical Trial | Endologix | Not applicable | Completed | Peripheral Arterial Disease | 202 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03119233) |
| December 19, 2016 | NCT02996396 | Nellix Registry Study: EVAS-Global | Endologix | Observational | Completed | Abdominal Aortic Aneurysm | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02996396) |
| October 31, 2016 | NCT02949297 | Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft Investigational Device Exemption (IDE) Study | Endologix | Not applicable | Completed | Aortic Aneurysm, Abdominal | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02949297) |
| June 15, 2015 | NCT02471638 | DETOUR I Clinical Study for Percutaneous Femoropopliteal Bypass | Endologix | Not applicable | Completed | Peripheral Arterial Disease | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02471638) |
| April 3, 2015 | NCT02407457 | Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices | Endologix | Not applicable | Completed | Abdominal Aortic Aneurysm | 455 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02407457) |
| January 29, 2014 | NCT02048514 | The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms | Endologix | Not applicable | Completed | Abdominal Aortic Aneurysms | 69 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02048514) |
| December 23, 2013 | NCT02018744 | Nellix® Registry Study: EVAS-Global | Endologix | Observational | Completed | Safety and Performance of the Nellix Endovascular Sealing System | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02018744) |
| August 28, 2013 | NCT01930071 | PQ Bypass Guide Wire Delivery System for Femoropopliteal Bypass | Endologix | Not applicable | Completed | Peripheral Arterial Disease | 4 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01930071) |
| November 14, 2012 | NCT01726257 | Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System | Endologix | Not applicable | Completed | Abdominal Aortic Aneurysm (AAA) | 333 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01726257) |
| December 14, 2011 | NCT01491945 | Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft System | Endologix | Not applicable | Completed | Abdominal Aortic Aneurysm | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01491945) |
| September 20, 2011 | NCT01437215 | Pilot Study of the Endologix Fenestrated Stent Graft System | Endologix | Not applicable | Completed | Juxtarenal Aortic Aneurysm, Pararenal Aortic Aneurysm | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01437215) |
| May 5, 2011 | NCT01348828 | Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System | Endologix | Not applicable | Completed | Abdominal Aortic Aneurysm | 49 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01348828) |
| February 17, 2010 | NCT01070069 | Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial | Endologix | Not applicable | Completed | Abdominal Aortic Aneurysm | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01070069) |
| August 21, 2008 | NCT00739401 | Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm | Endologix | Not applicable | Completed | Abdominal Aortic Aneurysm | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00739401) |
| June 27, 2008 | NCT00706394 | 34mm Cuff Study for Endovascular Repair of Abdominal Aortic Aneurysms | Endologix | Not applicable | Completed | Abdominal Aortic Aneurysm | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00706394) |
| October 12, 2007 | NCT00543270 | Powerlink Bifurcated Stent Graft Long-Term Follow-up Study | Endologix | Not applicable | Completed | Abdominal Aortic Aneurysm | 258 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00543270) |

## By phase

| Phase | Trials |
| --- | --- |
| Not applicable | 21 |
| Observational | 4 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 20 |
| Active not recruiting | 2 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Aortic Aneurysm, Abdominal | 15 |
| Peripheral Arterial Disease | 7 |
| Aneurysm | 5 |
| Endoleak | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Trucking companies in the United States](https://specstream.ai/data/businesses/trucking-companies/united-states)
- [B2B international trade companies in the United States](https://specstream.ai/data/businesses/b2b-international-trade-companies/united-states)
- [Comfort food restaurants in the United States](https://specstream.ai/data/businesses/comfort-food-restaurants/united-states)
- [Fertilizer stores in the United States](https://specstream.ai/data/businesses/fertilizer-stores/united-states)
- [Iron fabricators in the United States](https://specstream.ai/data/businesses/iron-fabricators/united-states)
- [Packaging companies in the United States](https://specstream.ai/data/businesses/packaging-companies/united-states)
